Published in J Virol on November 01, 1986
Infectious diseases associated with complement deficiencies. Clin Microbiol Rev (1991) 4.01
Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration. J Virol (1987) 3.74
A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G. J Virol (1989) 2.08
Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo. J Virol (1998) 1.26
Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice. J Virol (1994) 1.23
Structural basis of C3b binding by glycoprotein C of herpes simplex virus. J Virol (1992) 1.23
Disulfide bond structure determination and biochemical analysis of glycoprotein C from herpes simplex virus. J Virol (1996) 1.19
C3b receptor activity on transfected cells expressing glycoprotein C of herpes simplex virus types 1 and 2. J Virol (1988) 1.14
Herpes simplex virus type 2 glycoprotein G-negative clinical isolates are generated by single frameshift mutations. J Virol (1999) 1.13
Identification of C3b-binding regions on herpes simplex virus type 2 glycoprotein C. J Virol (1990) 1.02
Use of a glucocorticoid-inducible promoter for expression of herpes simplex virus type 1 glycoprotein gC1, a cytotoxic protein in mammalian cells. Mol Cell Biol (1989) 0.98
Dextran sulfate can act as an artificial receptor to mediate a type-specific herpes simplex virus infection via glycoprotein B. J Virol (1997) 0.92
The cytoplasmic domain of herpes simplex virus type 1 glycoprotein C is required for membrane anchoring. J Virol (1988) 0.89
Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C. J Virol (1992) 0.88
Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein. Immunology (1993) 0.80
Human Cytomegalovirus gH/gL Forms a Stable Complex with the Fusion Protein gB in Virions. PLoS Pathog (2016) 0.77
Separation of decay-accelerating and cofactor functional activities of Kaposi's sarcoma-associated herpesvirus complement control protein using monoclonal antibodies. Immunology (2007) 0.76
Prediction of protein conformation. Biochemistry (1974) 20.51
Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains. J Virol (1974) 16.33
Conformational parameters for amino acids in helical, beta-sheet, and random coil regions calculated from proteins. Biochemistry (1974) 12.07
Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells. J Virol (1976) 8.73
Membrane proteins specified by herpes simplex viruses. III. Role of glycoprotein VP7(B2) in virion infectivity. J Virol (1979) 6.72
The role of membrane receptors for C3b and C3d in phagocytosis. J Exp Med (1977) 6.19
Cell fusion induced by herpes simplex virus is promoted and suppressed by different viral glycoproteins. Proc Natl Acad Sci U S A (1977) 5.87
Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein. J Virol (1979) 5.52
Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane. Proc Natl Acad Sci U S A (1979) 5.08
A virion-associated glycoprotein essential for infectivity of herpes simplex virus type 1. Virology (1981) 4.37
Serological analysis of herpes simplex virus types 1 and 2 with monoclonal antibodies. Infect Immun (1982) 4.22
Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies. J Virol (1983) 4.04
Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature (1984) 3.80
Complement receptor is an inhibitor of the complement cascade. J Exp Med (1981) 3.65
Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody. J Virol (1984) 3.53
Anti-gD monoclonal antibodies inhibit cell fusion induced by herpes simplex virus type 1. Virology (1983) 3.40
Characterisation and physical mapping of an HSV-1 glycoprotein of approximately 115 X 10(3) molecular weight. Virology (1984) 3.06
Herpes simplex virus type 1 glycoprotein C-negative mutants exhibit multiple phenotypes, including secretion of truncated glycoproteins. J Virol (1984) 2.84
Glycoprotein gE of herpes simplex virus type 1: effects of anti-gE on virion infectivity and on virus-induced fc-binding receptors. J Virol (1982) 2.68
Similarities and differences in the Fc-binding glycoprotein (gE) of herpes simplex virus types 1 and 2 and tentative mapping of the viral gene for this glycoprotein. J Virol (1982) 2.55
Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice. Infect Immun (1983) 2.21
Identification of a new glycoprotein of herpes simplex virus type 1 and genetic mapping of the gene that codes for it. J Virol (1986) 2.07
Fc and C3 receptors induced by herpes simplex virus on cultured human endothelial cells. J Clin Invest (1982) 2.02
Possible role of Fc receptors on cells infected and transformed by herpesvirus: escape from immune cytolysis. Infect Immun (1978) 1.93
The involvement of herpes simplex virus type 1 glycoproteins in cell-mediated immunity. J Immunol (1981) 1.90
Cell-mediated immunity to herpes simplex virus: specificity of cytotoxic T cells. Infect Immun (1980) 1.71
Ocular disease pattern induced by herpes simplex virus is genetically determined by a specific region of viral DNA. J Exp Med (1982) 1.70
Epitopes of herpes simplex virus type 1 glycoprotein gC are clustered in two distinct antigenic sites. J Virol (1985) 1.60
Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity. J Virol (1985) 1.45
Specificity of Fc receptors induced by herpes simplex virus type 1: comparison of immunoglobulin G from different animal species. J Virol (1985) 1.39
Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes. J Immunol (1985) 1.28
Specificity of human natural killer cells in limiting dilution culture for determinants of herpes simplex virus type 1 glycoproteins. J Virol (1986) 1.16
In vitro neutralization of HSV-2: inhibition by binding of normal IgG and purified Fc to virion Fc receptor (FcR). J Med Virol (1984) 1.12
The human C3b receptor. Springer Semin Immunopathol (1983) 1.02
Binding of complement component C3b to glycoprotein C is modulated by sialic acid on herpes simplex virus type 1-infected cells. J Virol (1985) 0.98
Herpes simplex virus type 1 infection of endothelial, epithelial, and fibroblast cells induces a receptor for C3b. J Immunol (1985) 0.94
Biochemical characterization of peptides from herpes simplex virus glycoprotein gC: loss of CNBr fragments from the carboxy terminus of truncated, secreted gC molecules. J Virol (1984) 0.91
Competitive inhibition by human sera of mouse monoclonal antibody binding to glycoproteins C and D of herpes simplex virus types 1 and 2. J Virol (1985) 0.77
Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science (1998) 7.89
A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell (1999) 6.82
Cloning of herpes simplex virus type 1 sequences representing the whole genome. J Virol (1981) 5.66
Type-common CP-1 antigen of herpes simplex virus is associated with a 59,000-molecular-weight envelope glycoprotein. J Virol (1978) 5.12
Herpes simplex virus glycoprotein D bound to the human receptor HveA. Mol Cell (2001) 4.44
Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. N Engl J Med (1996) 4.43
Three classes of cell surface receptors for alphaherpesvirus entry. Virology (2000) 4.41
The limits and motivating potential of sensory stimuli as reinforcers for autistic children. J Appl Behav Anal (1981) 4.23
LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity (1998) 4.23
Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 A. J Mol Biol (1986) 4.16
Transcriptional and genetic analyses of the herpes simplex virus type 1 genome: coordinates 0.29 to 0.45. J Virol (1984) 4.09
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med (2001) 4.02
Structural analysis of the capsid polypeptides of herpes simplex virus types 1 and 2. J Virol (1980) 3.95
The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site. Proc Natl Acad Sci U S A (1974) 3.92
Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature (1984) 3.80
Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration. J Virol (1987) 3.74
Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody. J Virol (1984) 3.53
Interactions of protein antigens with antibodies. Proc Natl Acad Sci U S A (1996) 3.53
X-ray fiber diffraction and model-building study of polyguanylic acid and polyinosinic acid. J Mol Biol (1975) 3.50
Three-dimensional structure of an antibody-antigen complex. Proc Natl Acad Sci U S A (1987) 3.48
Differentiation of T cells induced by preparations from thymus and by nonthymic agents. J Exp Med (1973) 3.12
Isolation of a herpes simplex virus-specific antigenic fraction which stimulates the production of neutralizing antibody. J Virol (1972) 3.11
Teaching children with autism to seek information: acquisition of novel information and generalization of responding. J Appl Behav Anal (1995) 3.08
Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry. J Virol (1997) 3.05
Herpes simplex virus glycoprotein D can bind to poliovirus receptor-related protein 1 or herpesvirus entry mediator, two structurally unrelated mediators of virus entry. J Virol (1998) 3.00
Effect of tunicamycin on herpes simplex virus glycoproteins and infectious virus production. J Virol (1980) 2.99
High-frequency transfer of cloned herpes simplex virus type 1 sequences to mammalian cells by protoplast fusion. Mol Cell Biol (1981) 2.97
Physical mapping of the mutation in an antigenic variant of herpes simplex virus type 1 by use of an immunoreactive plaque assay. J Virol (1983) 2.96
Rapid diagnosis of influenza A infection by direct immunofluorescence of nasopharyngeal aspirates in adults. J Clin Microbiol (1979) 2.95
Synthesis and processing of glycoproteins gD and gC of herpes simplex virus type 1. J Virol (1980) 2.94
Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS (2001) 2.85
Mutations in herpes simplex virus type 1 genes encoding VP5 and VP23 abrogate capsid formation and cleavage of replicated DNA. J Virol (1993) 2.79
Localization of epitopes of herpes simplex virus type 1 glycoprotein D. J Virol (1985) 2.71
Purification of glycoprotein gD of herpes simplex virus types 1 and 2 by use of monoclonal antibody. J Virol (1982) 2.71
Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design. Proc Natl Acad Sci U S A (1999) 2.69
Fine mapping of antigenic site II of herpes simplex virus glycoprotein D. J Virol (1989) 2.68
Comparative structural analysis of glycoprotein gD of herpes simplex virus types 1 and 2. J Virol (1980) 2.65
Structure of an antibody-antigen complex: crystal structure of the HyHEL-10 Fab-lysozyme complex. Proc Natl Acad Sci U S A (1989) 2.65
Transcriptional control signals of a herpes simplex virus type 1 late (gamma 2) gene lie within bases -34 to +124 relative to the 5' terminus of the mRNA. Mol Cell Biol (1986) 2.65
Effect of monoclonal antibodies on limited proteolysis of native glycoprotein gD of herpes simplex virus type 1. J Virol (1982) 2.62
The pseudorabies virus gII gene is closely related to the gB glycoprotein gene of herpes simplex virus. J Virol (1987) 2.58
Rapid identification of nonessential genes of herpes simplex virus type 1 by Tn5 mutagenesis. Science (1987) 2.57
Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial. Ann Intern Med (1991) 2.42
Teaching language to nonverbal children--with emphasis on problems of generalization. Psychol Bull (1975) 2.35
Suppression of self-stimulation: three alternative strategies. J Appl Behav Anal (1979) 2.34
Expression of herpes simplex virus type 1 glycoprotein D deletion mutants in mammalian cells. J Virol (1988) 2.29
Deoxyribonucleic acid synthesis in synchronized mammalian KB cells infected with herpes simplex virus. J Virol (1971) 2.25
Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J Virol (1995) 2.24
Ribonucleotide reductase activity of synchronized KB cells infected with herpes simplex virus. J Virol (1972) 2.23
Oligomeric structure of glycoproteins in herpes simplex virus type 1. J Virol (1996) 2.22
Interactions of vesicular stomatitis virus structural proteins with HeLa plasma membranes. Nat New Biol (1971) 2.19
Legionnaires' disease in non-Legionnaires. A report of five cases. Ann Intern Med (1978) 2.18
Expression of herpes simplex virus beta and gamma genes integrated in mammalian cells and their induction by an alpha gene product. Mol Cell Biol (1983) 2.15
Complement component C3b binds directly to purified glycoprotein C of herpes simplex virus types 1 and 2. Microb Pathog (1987) 2.15
Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM. J Virol (1998) 2.11
A specific 15-bp TATA box promoter element is required for expression of a herpes simplex virus type 1 late gene. Genes Dev (1988) 2.11
Structural analysis of precursor and product forms of type-common envelope glycoprotein D (CP-1 antigen) of herpes simplex virus type 1. J Virol (1979) 2.10
Purification and properties of bovine thymosin. Ann N Y Acad Sci (1975) 2.08
A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G. J Virol (1989) 2.08
Structure-function analysis of soluble forms of herpes simplex virus glycoprotein D. J Virol (1996) 2.05
The first immunoglobulin-like domain of HveC is sufficient to bind herpes simplex virus gD with full affinity, while the third domain is involved in oligomerization of HveC. J Virol (1999) 2.03
Examination of the kinetics of herpes simplex virus glycoprotein D binding to the herpesvirus entry mediator, using surface plasmon resonance. J Virol (1998) 2.02
Fc and C3 receptors induced by herpes simplex virus on cultured human endothelial cells. J Clin Invest (1982) 2.02
Localization of a binding site for herpes simplex virus glycoprotein D on herpesvirus entry mediator C by using antireceptor monoclonal antibodies. J Virol (2000) 1.98
High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus-infected insect cells. J Virol (1994) 1.97